From the Departments of Pathology and Laboratory Medicine (Towne, Ginter).
Radiology (Michaels), Weill Cornell Medicine, New York, New York.
Arch Pathol Lab Med. 2022 Jan 2;146(2):213-219. doi: 10.5858/arpa.2020-0497-OA.
CONTEXT.—: Mucocele-like lesion of the breast (MLL) is an uncommon entity, and recent studies show low rates of upgrade from core needle biopsy (CNB) to excision.
OBJECTIVE.—: To evaluate features associated with upgrade of MLLs diagnosed on CNB.
DESIGN.—: Seventy-eight MLLs diagnosed on CNB from 1998-2019 and subsequent excisions were reviewed. Histologic parameters evaluated included the presence of atypia, presence and morphology of calcifications, and morphologic variant (classic [C-MLL], duct ectasia-like [DEL-MLL], or cystic mastopathy-like [CML-MLL]).
RESULTS.—: Overall, 45 MLLs lacked atypia and 33 were associated with atypia (atypical ductal hyperplasia, 32; atypical lobular hyperplasia, 1). Most were C-MLLs (61) with fewer DEL-MLLs (14) and CML-MLLs (3). Half showed both coarse and fine calcifications, with fewer showing only coarse or fine calcifications, and some showing none. Subsequent excision or clinical follow-up was available for 25 MLLs without atypia-of which 2 (8.0%) were upgraded to ductal carcinoma in situ (DCIS)-and 23 with atypia, of which 4 (17.4%) were upgraded to DCIS. No cases were upgraded to invasive carcinoma. All upgraded cases showed coarse calcifications on CNB, and all upgraded cases were associated with residual calcifications on post-CNB imaging.
CONCLUSIONS.—: Most MLLs present as calcifications and nearly half are associated with atypia. Upgrade to DCIS is twice as frequent in MLLs with atypia versus those without. A predominance of coarse calcifications and the presence of residual targeted calcifications following core biopsy may be associated with higher upgrade rates.
乳腺黏液样瘤样病变(MLL)是一种不常见的疾病,最近的研究表明,从核心针活检(CNB)升级为切除的比例较低。
评估与 CNB 诊断的 MLL 升级相关的特征。
回顾了 1998 年至 2019 年期间通过 CNB 诊断的 78 例 MLL 病例及其随后的切除术。评估的组织学参数包括存在非典型性、钙化的存在和形态以及形态学变异(经典型 [C-MLL]、导管扩张样 [DEL-MLL] 或囊性乳腺病样 [CML-MLL])。
总体而言,45 例 MLL 缺乏非典型性,33 例与非典型性相关(非典型性导管增生,32 例;非典型性小叶增生,1 例)。大多数为 C-MLL(61 例),DEL-MLL(14 例)和 CML-MLL(3 例)较少。半数表现为粗、细两种钙化,少数仅表现为粗钙化或细钙化,有些则无钙化。25 例无非典型性的 MLL 有后续切除或临床随访资料,其中 2 例(8.0%)升级为导管原位癌(DCIS);23 例有非典型性,其中 4 例(17.4%)升级为 DCIS。无病例升级为浸润性癌。所有升级病例在 CNB 上均表现为粗钙化,且所有升级病例在 CNB 后影像学上均存在残余钙化。
大多数 MLL 表现为钙化,近一半与非典型性有关。与无非典型性的 MLL 相比,有非典型性的 MLL 升级为 DCIS 的比例增加了一倍。粗钙化为主,核心针活检后存在靶向残余钙化可能与更高的升级率相关。